CN101843837A - Chinese medicament for treating diabetic oculopathy - Google Patents
Chinese medicament for treating diabetic oculopathy Download PDFInfo
- Publication number
- CN101843837A CN101843837A CN200910242157A CN200910242157A CN101843837A CN 101843837 A CN101843837 A CN 101843837A CN 200910242157 A CN200910242157 A CN 200910242157A CN 200910242157 A CN200910242157 A CN 200910242157A CN 101843837 A CN101843837 A CN 101843837A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- chinese
- chinese medicine
- chinese medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 27
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 13
- 208000030533 eye disease Diseases 0.000 title abstract description 3
- 241000222336 Ganoderma Species 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 3
- 241000628997 Flos Species 0.000 claims description 22
- 239000000843 powder Substances 0.000 claims description 17
- 239000002775 capsule Substances 0.000 claims description 16
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 10
- 241000180649 Panax notoginseng Species 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 8
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 210000004185 liver Anatomy 0.000 abstract description 4
- 238000005728 strengthening Methods 0.000 abstract description 4
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract description 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241001113925 Buddleja Species 0.000 abstract 1
- 240000002948 Ophiopogon intermedius Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 238000004097 X-ray Buerger Methods 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 230000004377 improving vision Effects 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 244000112814 pipewort Species 0.000 abstract 1
- 210000001508 eye Anatomy 0.000 description 5
- 206010047513 Vision blurred Diseases 0.000 description 4
- 241000207961 Sesamum Species 0.000 description 3
- 235000003434 Sesamum indicum Nutrition 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- AXONCVPTTFHNOI-UHFFFAOYSA-N kairine Chemical compound C1=CC(O)=C2N(C)CCCC2=C1 AXONCVPTTFHNOI-UHFFFAOYSA-N 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010012689 Diabetic retinopathy Diseases 0.000 description 2
- 241000201295 Euphrasia Species 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 210000000088 lip Anatomy 0.000 description 1
- 210000002189 macula lutea Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicament for treating diabetic oculopathy, and belongs to the field of Chinese medicaments for treating ophthalmology and otorhinolaryngology diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: dwarf lilyturf tuber, root of rehmannia, Chinese angelica, pale butterflybush flower, radix pseudo-ginseng, lucid ganoderma, buerger pipewort flower and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis, and clearing liver and improving vision, and has the advantages of obvious effect, exact medicinal effect and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment diseases of the five sense organs.
Background technology
Diabetic ophthalmopathy is one of diabetes common complication, mainly is diabetic retinopathy.The present Chinese medicine that is intended to treat diabetic ophthalmopathy, it is significantly not enough to exist some: the one, and effect is obvious inadequately, the 2nd, it is slower to take effect, to such an extent as to large quantities of diabetic eye patients are owing to can not get the effective treatment and the control of medicine, oculopathy progressively increases the weight of, eyes are dry and astringent, blurred vision, vision are seriously low, develop into blind at last.Patient and family members thereof are very dissatisfied to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of diabetic ophthalmopathy, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of diabetic ophthalmopathy adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Radix Ophiopogonis 4---30 parts in 30 parts of Radix Rehmanniae 4---30 parts of Radix Angelicae Sinensis 4---
Flos Buddlejae 4---12 parts of 30 portions of Radix Notoginseng 3---20 portions of Ganodermas 2---
Flos Eriocauli 4---30 parts
The Chinese medicine of this treatment diabetic ophthalmopathy is made by following method:
(1) by above-mentioned weight ratio, Radix Ophiopogonis, the Radix Rehmanniae, Radix Angelicae Sinensis, Flos Buddlejae, Flos Eriocauli are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Rehmanniae benefiting QI and nourishing blood in the side, the body resistance strengthening and constitution consolidating, enhancing human body immunity power; Radix Angelicae Sinensis, pseudo-ginseng blood-circulation-invigovating blood stasis dispelling strengthen the retinal microvascular circulation; Being aided with Flos Eriocauli evacuates wind-heat of liver channel and makes eye bright; The Flos Buddlejae clearing away liver-fire, the profit liver is dry and make eye bright; Close with YIN nourishing and the production of body fluid promoting Radix Ophiopogonis, relieving restlessness clears away heart-fire.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, the merit of liver heat removing and eyesight improving, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Radix Ophiopogonis, the 80 gram Radix Rehmanniae, 80 gram Radix Angelicae Sinensis 80 restrained
Flos Buddlejae 80 gram Radix Notoginseng 60 kairine sesames 40 grams
Flos Eriocauli 80 grams
Weight in accordance with regulations, with conventional water extraction process Radix Ophiopogonis, the Radix Rehmanniae, Radix Angelicae Sinensis, Flos Buddlejae, Flos Eriocauli are extracted, make extractum fine powder 120 grams, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 785 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Radix Ophiopogonis, the 160 gram Radix Rehmanniae, 200 gram Radix Angelicae Sinensis 120 restrained
Flos Buddlejae 160 gram Radix Notoginseng 100 kairine sesames 60 grams
Flos Eriocauli 160 grams
By above-mentioned same method, make 1428 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Radix Ophiopogonis, the 300 gram Radix Rehmanniae, 300 gram Radix Angelicae Sinensis 300 restrained
Flos Buddlejae 300 gram Radix Notoginseng 200 kairine sesames 120 grams
Flos Eriocauli 300 grams
By above-mentioned same method, make 2750 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
8 parts of 8 parts of Radix Angelicae Sinensis of 7 parts of Radix Rehmanniae Radix Ophiopogonis
4 parts of 6 portions of Ganodermas of 7 portions of Radix Notoginseng of Flos Buddlejae
7 parts of Flos Eriocaulis
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
20 parts of 25 parts of Radix Angelicae Sinensis of 20 parts of Radix Rehmanniae Radix Ophiopogonis
8 parts of 16 portions of Ganodermas of 20 portions of Radix Notoginseng of Flos Buddlejae
20 parts of Flos Eriocaulis
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science diabetic ophthalmopathy (retinopathy), through 6 routine clinical observations.Selecting the tcm diagnosis diabetic retinopathy is standard: diabetics is had a dizzy spell, and gum is too much; Binocular dryness, eye socket pain; Visual deterioration, blurred vision; That retina occurs is hemorrhage, edema, ooze out.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 3 examples, women's 3 examples do not have other serious disease, and the age is 43 years old-78 years old, 62.5 years old mean age.
Efficacy determination:
1, produce effects: gum is normal, eyes Clear and Bright; Binocular dryness disappears, and eyes are comfortable; Blurred vision is alleviated, and vision improves more than 0.1; White macula, macula lutea, the minimizing of blood stain quantity appear in the optical fundus, and area dwindles.
2, effective: the dry and astringent disappearance of eyes, blurred vision is alleviated.
3, invalid: the disease no change.
During clinical experiment, except that the antidiabetic drug that diabetics is necessary is taken (medicine is constant, amount is constant) as usual, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 3 months after, symptom is obviously improved.6 philtrums of clinical experiment, produce effects 3 people, effective 2 people, invalid 1 people, total effective rate 83.3%.
Claims (1)
1. a Chinese medicine for the treatment of diabetic ophthalmopathy adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Radix Ophiopogonis 4---30 parts in 30 parts of Radix Rehmanniae 4---30 parts of Radix Angelicae Sinensis 4---
Flos Buddlejae 4---12 parts of 30 portions of Radix Notoginseng 3---20 portions of Ganodermas 2---
Flos Eriocauli 4---30 parts
The Chinese medicine of this treatment diabetic ophthalmopathy is made by following method:
(1) by above-mentioned weight ratio, Radix Ophiopogonis, the Radix Rehmanniae, Radix Angelicae Sinensis, Flos Buddlejae, Flos Eriocauli are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102421574A CN101843837B (en) | 2009-12-09 | 2009-12-09 | Chinese medicament for treating diabetic oculopathy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102421574A CN101843837B (en) | 2009-12-09 | 2009-12-09 | Chinese medicament for treating diabetic oculopathy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101843837A true CN101843837A (en) | 2010-09-29 |
| CN101843837B CN101843837B (en) | 2011-07-27 |
Family
ID=42768775
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102421574A Expired - Fee Related CN101843837B (en) | 2009-12-09 | 2009-12-09 | Chinese medicament for treating diabetic oculopathy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101843837B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102318701A (en) * | 2011-10-10 | 2012-01-18 | 王璐 | Eyesight improving health-care tea |
| CN116870079A (en) * | 2023-08-11 | 2023-10-13 | 北京创联惠通生物科技有限公司 | Traditional Chinese medicine composition for tonifying qi and blood as well as preparation method and application thereof |
-
2009
- 2009-12-09 CN CN2009102421574A patent/CN101843837B/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102318701A (en) * | 2011-10-10 | 2012-01-18 | 王璐 | Eyesight improving health-care tea |
| CN116870079A (en) * | 2023-08-11 | 2023-10-13 | 北京创联惠通生物科技有限公司 | Traditional Chinese medicine composition for tonifying qi and blood as well as preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101843837B (en) | 2011-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843837B (en) | Chinese medicament for treating diabetic oculopathy | |
| CN101530502B (en) | Traditional Chinese medicine for treating diabetic fundus hemorrhage | |
| CN101884693B (en) | Traditional Chinese medicine for treating diabetic eye diseases | |
| CN101843836B (en) | Chinese medicament for treating diabetic oculopathy | |
| CN101843786A (en) | Chinese medicament for treating diabetic eyeground pathological changes | |
| CN101843834B (en) | Chinese medicament for treating diabetic eyeground pathological changes | |
| CN101843857B (en) | Chinese medicament for treating diabetic eyeground pathological changes | |
| CN101843770A (en) | Chinese medicament for treating diabetic oculopathy | |
| CN101843788A (en) | Chinese medicament for treating diabetic oculopathy | |
| CN101391071B (en) | Traditional Chinese medicine for treating diabetic ocular fundus diseases | |
| CN101843772A (en) | Chinese medicament for treating diabetic oculopathy | |
| CN102389484A (en) | Traditional Chinese medicine for treating diabetic retinopathy | |
| CN101843727A (en) | Chinese medicament for treating diabetic oculopathy | |
| CN101966258A (en) | Traditional Chinese medicine for treating diabetic retinopathy | |
| CN101897809A (en) | Traditional Chinese medicine for treating diabetic retinopathy | |
| CN102018757A (en) | Traditional Chinese medicine for treating eyeground pathological changes caused by diabetes | |
| CN101940659A (en) | Traditional Chinese medicine for treating diabetic eye disease | |
| CN101953939A (en) | Chinese medicament for treating diabetic eye diseases | |
| CN101843725A (en) | Chinese medicament for treating diabetic oculopathy | |
| CN101843774A (en) | Chinese medicament for treating diabetic eyeground pathological changes | |
| CN101843785A (en) | Chinese medicament for treating diabetic eyeground pathological changes | |
| CN101843752A (en) | Chinese medicament for treating diabetic eyeground pathological changes | |
| CN101972343A (en) | Traditional Chinese medicine for treating diabetic oculopathy | |
| CN101843728A (en) | Chinese medicament for treating diabetic oculopathy | |
| CN102389495A (en) | Traditional Chinese medicine for curing diabetic retinopathy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: LIU XINZHUANG Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20150722 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20150722 Address after: 100040 Beijing city Shijingshan District double Jinyuan District 16 Building 2 unit 1102 Patentee after: Liu Xinzhuang Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room Patentee before: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT Co.,Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110727 |